NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Activist Hedge Fund Ancora Pushes Ashland to Sell – Stock Could Jump 30%

Activist hedge fund Ancora has built a major stake in Ashland and is demanding the company sell itself. Proxy fight threatened if no progress by September.

Activist Hedge Fund Ancora Pushes Ashland to Sell – Stock Could Jump 30%
Credit: Ancora
Already have an account? Sign in.
06/09/2026 · 1:40 PM
ASH
/ Don’t stop at just one post.

Related↓

Ashland Explores Sale After Takeover Interest From PE Firms and Activist Pressure
08/07/2026 · 4:33 PM

Ashland Explores Sale After Takeover Interest From PE Firms and Activist Pressure

Ashland is exploring a potential sale after takeover interest from PE firms like Advent, Apollo & Carlyle, following activist pressure from Ancora.

/ Subscriber only
/ Read more

Feed↓

MARA Misses Q2 Revenue and Earnings Estimates as Bitcoin Weakness Hits Results
08/07/2026 · 5:04 PM

MARA Misses Q2 Revenue and Earnings Estimates as Bitcoin Weakness Hits Results

Revenue hit $174.9M (down 27%), net loss $1.60/share from Bitcoin mark-to-market losses.

/ Subscriber only
Ashland Explores Sale After Takeover Interest From PE Firms and Activist Pressure
08/07/2026 · 4:33 PM

Ashland Explores Sale After Takeover Interest From PE Firms and Activist Pressure

Ashland is exploring a potential sale after takeover interest from PE firms like Advent, Apollo & Carlyle, following activist pressure from Ancora.

/ Subscriber only
Evercore Upgrades Intellia After New Hypothesis Explains Nex-z Liver Safety Signal
08/07/2026 · 3:59 PM

Evercore Upgrades Intellia After New Hypothesis Explains Nex-z Liver Safety Signal

Intellia stock upgraded after solving liver risk issue; trials resume, new safety steps added, and another drug shows strong results.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe